Nexera Technologies Ltd (NEXR) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.81

From 52W high−98.35%

Volume37937.00

Market cap$430863.15

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataOct 19, 2026

Open

$0.81

From 52W high

−98.35%

Volume

37937.00

Market cap

$430863.15

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

P/E (TTM)

—

RSI (14)

27.5

MomentumView details →

1D Return

−6.32%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.1x

EV/Sales

0.0x

P/S (TTM)

0.0x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

11.36%

Net Margin

−26.94%

EBITDA Margin

−30.69%

ROE (TTM)

−129.20%

ROA (TTM)

−82.25%

Asset Turnover

1.36x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+42.15%

EPS CAGR 3Y

+97.14%

EBITDA YoY

—

MomentumView details →

1D Return

−6.32%

YTD Return

—

1Y Return

—

RSI (14)

27.5

vs 50D SMA

−54.32%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

2.41x

Quick Ratio

0.63x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

24.18M

Net Income (TTM)

−6.51M

Op. CF (TTM)

−8.70M

Latest newsMore news →

No recent news for NEXR.

Similar companies

BriaCell Therapeutics Corp. WarrantBCTXZ Lyra Therapeutics, Inc.LYRA NRx Pharmaceuticals, Inc.NRXPW CDT Equity Inc.CDTTW NeuroSense Therapeutics Ltd.NRSNW Propanc Biopharma, Inc.PPCB Find similar companies →

Latest newsMore news →

No recent news for NEXR.